Cardiac/cardiovascular drug NOS, adverse effect: Difference between revisions
Ttenbergen (talk | contribs) mNo edit summary |
|||
| (13 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle = No corresponding old article | | OldDxArticle = No corresponding old article | ||
| CurrentStatus = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = not assigned | | InitialEditorAssigned = not assigned | ||
}} | }} | ||
| Line 14: | Line 14: | ||
== Additional Info == | == Additional Info == | ||
*This code is for adverse effect of any cardiac drug used appropriately | *This code is for adverse effect of any cardiac drug used appropriately | ||
Excludes: | Excludes: | ||
*[[Beta-blocker | *[[Beta-blocker, adverse effect]] | ||
*[[Calcium channel blocker drug, adverse effect]] | *[[Calcium channel blocker drug, adverse effect]] | ||
*[[Cardiac/cardiovascular drug NOS, | *[[Cardiac/cardiovascular drug NOS, overdose/toxicity]] | ||
*Amidarone lung - see [[Interstitial lung disease, drug-induced (acute or chronic)]] | |||
Includes | '''Includes''' | ||
* ACE inhibitor | * ACE inhibitor | ||
* ARBs | * ARBs | ||
* digoxin | * digoxin | ||
* other antihypertensives | * other antihypertensives | ||
* lipid drugs | * lipid drugs | ||
* Nitroglycerine | |||
* Vasopressors | |||
{{ICD10 Guideline adverse effect}} | {{ICD10 Guideline adverse effect}} | ||
| Line 33: | Line 36: | ||
{{ListICD10Category | categoryName = Adverse effect}} | {{ListICD10Category | categoryName = Adverse effect}} | ||
{{ListICD10Category | categoryName = Overdose}} | {{ListICD10Category | categoryName = Overdose}} | ||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
* [[Anaphylactic reaction (anaphylaxis)]] | |||
* [[ Allergic reaction (allergy), NOS]] | |||
* [[Skin rash, drug-induced (drug eruption)]] | |||
== Related CCI Codes == | == Related CCI Codes == | ||